TVTX Operating Cash Flow (Statement)
Travere Therapeutics Inc · Operating Cash Flow (Statement)
TVTX Operating Cash Flow (Statement)
Latest reported$92.70Mperiod ending
TVTX TTM Cash from Operations ($4.66K → $92.70M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TVTX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 92,700,000 | |
| 39,612,000 | |
| 37,784,000 | |
| -58,614,000 | |
| -115,438,000 | |
| -160,664,000 | |
| -237,475,000 | |
| -272,228,000 | |
| -288,855,000 | |
| -317,909,000 | |
| -280,021,000 | |
| -264,188,000 | |
| -244,579,000 | |
| -212,088,000 | |
| -186,291,000 | |
| -158,528,000 | |
| -86,940,000 | |
| -43,638,000 | |
| -14,792,000 | |
| -1,785,000 | |
| -27,113,000 | |
| -40,062,000 | |
| -42,743,000 | |
| -33,365,000 | |
| -54,221,000 | |
| -66,877,000 | |
| -58,214,000 | |
| -57,287,000 | |
| -47,065,000 | |
| -30,716,000 | |
| -24,958,000 | |
| -22,247,000 | |
| -12,709,000 | |
| -4,555,000 | |
| 7,403,000 | |
| 1,494,000 | |
| 599,000 | |
| -805,000 | |
| -1,596,000 | |
| 2,618,000 | |
| -697,000 | |
| 3,212,433 | |
| -554,000 | |
| -7,099,447 | |
| -24,028,362 | |
| -43,377,510 | |
| -45,849,750 | |
| -44,902,029 | |
| -32,057,574 | |
| -22,816,257 | |
| -17,589,168 | |
| -2,746,181,433 | |
| -2,743,997,229 | |
| -2,741,788,840 | |
| -2,737,210,238 | |
| -471,265 | |
| -34 | |
| -49 | |
| -647 | |
| -720 | |
| -3,821 | |
| -3,815 | |
| 4,660 | |
| 232 | |
| -18 |